Using the dox-inducible IKFM transgenic model, we previously reported that increased canonical NF-κB signaling in macrophages is sufficient to inhibit metastasis to the lungs of breast cancer or melanoma cells in the context of a tail vein injection model [19, 21]. Here, NFKB1 is linked to breast cancer.